Cargando…

Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece

Detalles Bibliográficos
Autores principales: Alevizopoulos, Georgios, Nystazaki, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Universitaria de Zaragoza para el Progreso de la Psiquiatría y la Salud Mental. Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182413/
https://www.ncbi.nlm.nih.gov/pubmed/34121789
http://dx.doi.org/10.1016/j.ejpsy.2021.03.001
_version_ 1783704202188423168
author Alevizopoulos, Georgios
Nystazaki, Maria
author_facet Alevizopoulos, Georgios
Nystazaki, Maria
author_sort Alevizopoulos, Georgios
collection PubMed
description
format Online
Article
Text
id pubmed-8182413
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Asociación Universitaria de Zaragoza para el Progreso de la Psiquiatría y la Salud Mental. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-81824132021-06-07 Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece Alevizopoulos, Georgios Nystazaki, Maria Eur J Psychiatry Letters to the Editor Asociación Universitaria de Zaragoza para el Progreso de la Psiquiatría y la Salud Mental. Published by Elsevier España, S.L.U. 2021 2021-06-07 /pmc/articles/PMC8182413/ /pubmed/34121789 http://dx.doi.org/10.1016/j.ejpsy.2021.03.001 Text en © 2021 Asociación Universitaria de Zaragoza para el Progreso de la Psiquiatría y la Salud Mental. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters to the Editor
Alevizopoulos, Georgios
Nystazaki, Maria
Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
title Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
title_full Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
title_fullStr Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
title_full_unstemmed Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
title_short Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
title_sort long acting injectable antipsychotics: ongoing use during the covid-19 pandemic and successful use of internet-based support in greece
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182413/
https://www.ncbi.nlm.nih.gov/pubmed/34121789
http://dx.doi.org/10.1016/j.ejpsy.2021.03.001
work_keys_str_mv AT alevizopoulosgeorgios longactinginjectableantipsychoticsongoinguseduringthecovid19pandemicandsuccessfuluseofinternetbasedsupportingreece
AT nystazakimaria longactinginjectableantipsychoticsongoinguseduringthecovid19pandemicandsuccessfuluseofinternetbasedsupportingreece